As of 2024-12-12, the Relative Valuation of Isofol Medical AB (publ) (ISOFOL.ST) is (7.08) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 2.24 SEK, the upside of Isofol Medical AB (publ) based on Relative Valuation is -416.1%.
The range of the Relative Valuation is (4.05) - (7.64) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 31.4x | 31.0x |
| Forward P/E multiples | 16.6x - 34.4x | 27.2x |
| Fair Price | (4.05) - (7.64) | (7.08) |
| Upside | -280.7% - -441.0% | -416.1% |
| Date | P/E |
| 2024-12-11 | -9.21 |
| 2024-12-10 | -9.17 |
| 2024-12-09 | -10.36 |
| 2024-12-06 | -10.95 |
| 2024-12-05 | -10.65 |
| 2024-12-04 | -11.22 |
| 2024-12-03 | -11.06 |
| 2024-12-02 | -11.71 |
| 2024-11-29 | -12.29 |
| 2024-11-28 | -11.84 |
| 2024-11-27 | -11.73 |
| 2024-11-26 | -12.13 |
| 2024-11-25 | -12.33 |
| 2024-11-22 | -12.08 |
| 2024-11-21 | -12.31 |
| 2024-11-20 | -13.65 |
| 2024-11-19 | -13.46 |
| 2024-11-18 | -11.86 |
| 2024-11-15 | -11.71 |
| 2024-11-14 | -11.78 |
| 2024-11-13 | -11.78 |
| 2024-11-12 | -12.37 |
| 2024-11-11 | -12.95 |
| 2024-11-08 | -13.44 |
| 2024-11-07 | -13.38 |
| 2024-11-06 | -13.69 |
| 2024-11-05 | -14.39 |
| 2024-11-04 | -15.08 |
| 2024-11-01 | -14.86 |
| 2024-10-31 | -15.54 |
| 2024-10-30 | -15.31 |
| 2024-10-29 | -15.00 |
| 2024-10-28 | -15.52 |
| 2024-10-25 | -15.74 |
| 2024-10-24 | -15.04 |
| 2024-10-23 | -14.84 |
| 2024-10-22 | -16.36 |
| 2024-10-21 | -14.18 |
| 2024-10-18 | -16.24 |
| 2024-10-17 | -16.59 |
| 2024-10-16 | -13.65 |
| 2024-10-15 | -13.67 |
| 2024-10-14 | -11.82 |
| 2024-10-11 | -12.33 |
| 2024-10-10 | -11.06 |
| 2024-10-09 | -10.93 |
| 2024-10-08 | -10.77 |
| 2024-10-07 | -10.73 |
| 2024-10-04 | -10.81 |
| 2024-10-03 | -10.77 |